Because plasma concentrations of AVP might be inappropriately low in septic shock [57] and, as seen in this study, plasmid DNA can increase concentration of AVP and improve MAP, we suggested that plasmid DNA constitutes a novel approach with therapeutic potential in sepsis that may have clinical applications. This evidence concerns the gene AVP and Sepsis.